• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number H060040A
Device Problem Occlusion Within Device (1423)
Patient Problem Thrombosis (2100)
Event Date 09/09/2016
Event Type  Injury  
Manufacturer Narrative
No lot number information was supplied; therefore, no review of the manufacturing paperwork could be performed.Concomitant medications were aspirin (acetylsalicylic acid), amlodipine, simvastatin, hydralazine, clonidine, carvedilol, renvela (sevelamer carbonate), sensipar (cinacalcet hydrochloride), and nephro-vite (ascorbic acid, biotin, calcium pantothenate, cyanocobalamin, folic acid, nicotinamide, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride).
 
Event Description
It was reported to gore that on (b)(6) 2016, a study patient was implanted with a gore propaten vascular graft in the right upper arm as a conduit.The patient was believed to be on plavix (clopidogrel) and therefore was not started on aspirin as part of the discharge orders.On (b)(6) 2016, the patient was not taking aspirin and patient denied taking plavix.The patient was started on aspirin 81 mg on (b)(6) 2016.On (b)(6) 2016, the patient's graft was found to be occluded.The patient had a procedure of a fistulogram, mechanical thrombectomy and installation of tissue plasminogen activator (tpa) and heparin for a thrombosis of his vascular study conduit.A balloon angioplasty using an 8mm x 6cm balloon was performed to macerate the thrombus within the conduit.Heparin and tpa was instilled and a venography revealed normal outflow and a good thrill was restored.The occlusion was resolved successfully on (b)(6) 2016.On (b)(6) 2016, the study patient experienced thrombosis in the implanted gore propaten vascular graft.On the same date, the patient underwent resection of the arteriovenous (av) graft, placement of a new 6mm gore propaten vascular graft, and the event was resolved.
 
Manufacturer Narrative
Additional information was received from complainant / user facility.
 
Event Description
On (b)(6) 2016, the patient underwent resection of the arteriovenous (av) graft and placement of a new 6 mm av graft in the right, brachioaxillary region due to poor incorporation of the graft.
 
Manufacturer Narrative
Explant date - date was entered based on user facility information reporting a resection of the graft.It is unknown if all or part of the graft was explanted; it was not returned to gore for evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE PROPATEN® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
genevieve begay
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key5997289
MDR Text Key56398804
Report Number2017233-2016-00770
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062161
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type user facility
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/17/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberH060040A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/04/2016
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received10/19/2016
11/15/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age46 YR
Patient Weight83
-
-